{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:49:42Z","timestamp":1790401782541,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015086","name":"AOP Orphan Pharmaceuticals AG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015086","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Amomed Pharma GmbH","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-3024-6","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T14:27:56Z","timestamp":1542637676000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9600-8618","authenticated-orcid":false,"given":"Martin","family":"Unger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Radermacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rehberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Trimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gottfried","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"Cerny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Dost\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Siebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Guarracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pratesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Biancofiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Girardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Kadlecova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Z\u00f6rer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Grohmann-Izay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Krejcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Klade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Krumpl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"key":"3024_CR1","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJM199305203282008","volume":"328","author":"JE Parrillo","year":"1993","unstructured":"Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993;328:1471\u20137.","journal-title":"N Engl J Med"},{"key":"3024_CR2","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1007\/s001340000601","volume":"26","author":"G Marx","year":"2000","unstructured":"Marx G, Vangerow B, Burczyk C, Gratz KF, Maassen N, Cobas Meyer M, et al. Evaluation of noninvasive determinants for capillary leakage syndrome in septic shock patients. Intensive Care Med. 2000;26:1252\u20138.","journal-title":"Intensive Care Med"},{"key":"3024_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0008-6363(98)00249-1","volume":"41","author":"K Bhagat","year":"1999","unstructured":"Bhagat K, Hingorani AD, Palacios M, Charles IG, Vallance P. Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS. Cardiovasc Res. 1999;41:754\u201364.","journal-title":"Cardiovasc Res"},{"key":"3024_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","volume":"41","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580\u2013637.","journal-title":"Crit Care Med"},{"key":"3024_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1139\/Y09-012","volume":"87","author":"K Werdan","year":"2009","unstructured":"Werdan K, Schmidt H, Ebelt H, Zorn-Pauly K, Koidl B, Hoke RS, et al. Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol. 2009;87:266\u201374.","journal-title":"Can J Physiol Pharmacol"},{"key":"3024_CR6","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1097\/01.CCM.0000178181.91250.99","volume":"33","author":"H Schmidt","year":"2005","unstructured":"Schmidt H, M\u00fcller-Werdan U, Hoffmann T, Francis DP, Piepoli MF, Rauchhaus M, et al. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med. 2005;33:1994\u20132002.","journal-title":"Crit Care Med"},{"key":"3024_CR7","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s00134-012-2531-2","volume":"38","author":"CA Schmittinger","year":"2012","unstructured":"Schmittinger CA, Torgersen C, Luckner G, Schr\u00f6der DCH, Lorenz I, D\u00fcnser MW. Adverse cardiac events during catecholamine vasopressor therapy: A prospective observational study. Intensive Care Med. 2012;38:950\u20138.","journal-title":"Intensive Care Med"},{"key":"3024_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.CCM.0000150028.64264.14","volume":"33","author":"O Sander","year":"2005","unstructured":"Sander O, Welters ID, Fo\u00ebx P, Sear JW. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med. 2005;33:81\u20138.","journal-title":"Crit Care Med"},{"key":"3024_CR9","first-page":"187","volume":"11","author":"A Rudiger","year":"2013","unstructured":"Rudiger A, Singer M. The heart in sepsis: from basic mechanisms to clinical management. Curr Vasc Pharmacol. 2013;11:187\u201395.","journal-title":"Curr Vasc Pharmacol"},{"key":"3024_CR10","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.2013.278477","volume":"310","author":"A Morelli","year":"2013","unstructured":"Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock. JAMA. 2013;310:1683.","journal-title":"JAMA"},{"key":"3024_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/qjmed\/hcm074","volume":"100","author":"L Leibovici","year":"2007","unstructured":"Leibovici L, Gafter-Gvili A, Paul M, Almanasreh N, Tacconelli E, Andreassen S, et al. Relative tachycardia in patients with sepsis: An independent risk factor for mortality. QJM. 2007;100:629\u201334.","journal-title":"QJM"},{"key":"3024_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/0885066609340519","volume":"24","author":"MW D\u00fcnser","year":"2009","unstructured":"D\u00fcnser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress. J Intensive Care Med. 2009;24:293\u2013316.","journal-title":"J Intensive Care Med"},{"key":"3024_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/SHK.0000000000000673","volume":"46","author":"N Hayase","year":"2016","unstructured":"Hayase N, Yamamoto M, Asada T, Isshiki R, Yahagi N, Doi K. Association of heart rate with N-terminal pro-B-type natriuretic peptide in septic patients: a prospective observational cohort study. Shock. 2016;46:642\u20138.","journal-title":"Shock"},{"key":"3024_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/CCM.0000000000000553","volume":"43","author":"NAR Vellinga","year":"2015","unstructured":"Vellinga NAR, Boerma EC, Koopmans M, Donati A, Dubin A, Shapiro NI, et al. International study on microcirculatory shock occurrence in acutely Ill patients. Crit Care Med. 2015;43:48\u201356.","journal-title":"Crit Care Med"},{"key":"3024_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00392-011-0375-3","volume":"101","author":"RS Hoke","year":"2012","unstructured":"Hoke RS, M\u00fcller-Werdan U, Lautenschl\u00e4ger C, Werdan K, Ebelt H. Heart rate as an independent risk factor in patients with multiple organ dysfunction: A prospective, observational study. Clin Res Cardiol. 2012;101:139\u201347.","journal-title":"Clin Res Cardiol"},{"key":"3024_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00392-013-0571-4","volume":"102","author":"W Grander","year":"2013","unstructured":"Grander W, M\u00fcllauer K, Koller B, Tilg H, D\u00fcnser M. Heart rate before ICU discharge: A simple and readily available predictor of short- and long-term mortality from critical illness. Clin Res Cardiol. 2013;102:599\u2013606.","journal-title":"Clin Res Cardiol"},{"key":"3024_CR17","doi-asserted-by":"publisher","first-page":"e1247","DOI":"10.1097\/CCM.0000000000002721","volume":"45","author":"W Du","year":"2017","unstructured":"Du W, Liu D, Long Y, Wang X. The \u03b2-blocker esmolol restores the vascular waterfall phenomenon after acute endotoxemia. Crit Care Med. 2017;45:e1247\u201353.","journal-title":"Crit Care Med"},{"key":"3024_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s13054-016-1580-2","volume":"20","author":"C Wei","year":"2016","unstructured":"Wei C, Louis H, Schmitt M, Albuisson E, Orlowski S, Levy B, et al. Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock. Crit Care. 2016;20:407.","journal-title":"Crit Care"},{"key":"3024_CR19","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1097\/CCM.0000000000001078","volume":"43","author":"A Kimmoun","year":"2015","unstructured":"Kimmoun A, Louis H, Al Kattani N, Delemazure J, Dessales N, Wei C, et al. \u03b21-adrenergic inhibition improves cardiac and vascular function in experimental septic shock. Crit Care Med. 2015;43:e332\u201340.","journal-title":"Crit Care Med"},{"issue":"6","key":"3024_CR20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s13054-014-0610-1","volume":"18","author":"P Calzavacca","year":"2014","unstructured":"Calzavacca P, Lankadeva YR, Bailey SR, Bailey M, Bellomo R, May CN. Effects of selective \u03b21-adrenoceptor blockade on cardiovascular and renal function and circulating cytokines in ovine hyperdynamic sepsis. Crit Care. 2014;18(6):610.","journal-title":"Crit Care"},{"key":"3024_CR21","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s00134-011-2236-y","volume":"37","author":"J Aboab","year":"2011","unstructured":"Aboab J, Sebille V, Jourdain M, Mangalaboyi J, Gharbi M, Mansart A, et al. Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med. 2011;37:1344\u201351.","journal-title":"Intensive Care Med"},{"key":"3024_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/SHK.0b013e3181863689","volume":"31","author":"S Hagiwara","year":"2009","unstructured":"Hagiwara S, Iwasaka H, Maeda H, Noguchi T. Landiolol, an ultrashort-acting \u03b21-adrenoceptor antagonist, has protective effects in an lps-induced systemic inflammation model. Shock. 2009;31:515\u201320.","journal-title":"Shock"},{"key":"3024_CR23","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1097\/01.CCM.0000182796.11329.3B","volume":"33","author":"T Suzuki","year":"2005","unstructured":"Suzuki T, Morisaki H, Serita R, Yamamoto M, Kotake Y, Ishizaka A, et al. Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med. 2005;33:2294\u2013301.","journal-title":"Crit Care Med"},{"key":"3024_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/CCM.0b013e3181c03dfa","volume":"38","author":"GL Ackland","year":"2010","unstructured":"Ackland GL, Yao ST, Rudiger A, Dyson A, Stidwill R, Poputnikov D, et al. Cardioprotection, attenuated systemic inflammation, and survival benefit of \u03b21-adrenoceptor blockade in severe sepsis in rats. Crit Care Med. 2010;38:388\u201394.","journal-title":"Crit Care Med"},{"key":"3024_CR25","first-page":"390","volume":"29","author":"S Wang","year":"2017","unstructured":"Wang S, Li M, Duan J, Yi L, Huang X, Chen D, et al. Effect of esmolol on hemodynamics and clinical outcomes in patients with septic shock. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017;29:390\u20135.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"3024_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00508-012-0209-y","volume":"124","author":"M Balik","year":"2012","unstructured":"Balik M, Ruliseky J, Leden P, Zakharchenko M, Otahal M, Bartakova H, et al. Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. Wien Klin Wochenschr. 2012;124:552\u20136.","journal-title":"Wien Klin Wochenschr"},{"key":"3024_CR27","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.4103\/0366-6999.185856","volume":"129","author":"W Du","year":"2016","unstructured":"Du W, Wang X-T, Long Y, Liu D-W. Efficacy and safety of esmolol in treatment of patients with septic shock. Chin Med J. 2016;129:1658.","journal-title":"Chin Med J"},{"key":"3024_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1038034","volume":"2016","author":"X Shang","year":"2016","unstructured":"Shang X, Wang K, Xu J, Gong S, Ye Y, Chen K, et al. The effect of esmolol on tissue perfusion and clinical prognosis of patients with severe sepsis: a prospective cohort study. Biomed Res Int. 2016;2016:1\u20137.","journal-title":"Biomed Res Int"},{"key":"3024_CR29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s40261-015-0325-3","volume":"35","author":"Z Wang","year":"2015","unstructured":"Wang Z, Wu Q, Nie X, Guo J, Yang C. Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial. Clin Drug Investig. 2015;35:707\u201316.","journal-title":"Clin Drug Investig"},{"key":"3024_CR30","first-page":"759","volume":"27","author":"L Xinqiang","year":"2015","unstructured":"Xinqiang L, Weiping H, Miaoyun W, Wenxin Z, Wenqiang J, Shenglong C, et al. Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015;27:759\u201363.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"3024_CR31","first-page":"885","volume":"27","author":"Y Tao","year":"2015","unstructured":"Tao Y, Jingyi W, Xiaogan J, Weihua L, Xiaoju J. Effect of esmolol on fluid responsiveness and hemodynamic parameters in patients with septic shock. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015;27:885\u20139.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"3024_CR32","first-page":"714","volume":"26","author":"S Yang","year":"2014","unstructured":"Yang S, Liu Z, Yang W, Zhang G, Hou B, Liu J, et al. Effects of the beta-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26:714\u20137.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"3024_CR33","first-page":"1243","volume":"93","author":"JX Chen","year":"2013","unstructured":"Chen JX, Sun J, Liu YY, Jia BH. Effects of adrenergic beta-1 antagonists on hemodynamics of severe septic patients. Zhonghua Yi Xue Za Zhi. 2013;93:1243\u20136.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"3024_CR34","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1097\/CCM.0b013e31828a678d","volume":"41","author":"A Morelli","year":"2013","unstructured":"Morelli A, Donati A, Ertmer C, Rehberg S, Kampmeier T, Orecchioni A, et al. Microvascular effects of heart rate control with esmolol in patients with septic shock: A pilot study. Crit Care Med. 2013;41:2162\u20138.","journal-title":"Crit Care Med"},{"key":"3024_CR35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s40265-013-0077-4","volume":"73","author":"GL Plosker","year":"2013","unstructured":"Plosker GL. Landiolol: A review of its use in intraoperative and postoperative tachyarrhythmias. Drugs. 2013;73:959\u201377.","journal-title":"Drugs"},{"key":"3024_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1254\/jphs.11202FP","volume":"118","author":"S Shibata","year":"2012","unstructured":"Shibata S, Okamoto Y, Endo S, Ono K. Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts. J Pharmacol Sci. 2012;118:255\u201365.","journal-title":"J Pharmacol Sci"},{"key":"3024_CR37","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/BF03016588","volume":"48","author":"J Sasao","year":"2001","unstructured":"Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting \u03b2-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anesth. 2001;48:985\u20139.","journal-title":"Can J Anesth"},{"key":"3024_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/FJC.0000000000000495","volume":"70","author":"G Krumpl","year":"2017","unstructured":"Krumpl G, Ul\u010d I, Trebs M, Kadlecov\u00e1 P, Hodisch J, Maurer G, et al. Pharmacodynamic and -kinetic behavior of low-, intermediate-, and high-dose landiolol during long-term infusion in whites. J Cardiovasc Pharmacol. 2017;70:42\u201351.","journal-title":"J Cardiovasc Pharmacol"},{"key":"3024_CR39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, CS D, Seymour C, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"3024_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","volume":"45","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign. Crit Care Med. 2017;45:486\u2013552.","journal-title":"Crit Care Med"},{"key":"3024_CR41","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1185\/03007995.2015.1062357","volume":"31","author":"F Sanfilippo","year":"2015","unstructured":"Sanfilippo F, Santonocito C, Morelli A, Foex P. Beta-blocker use in severe sepsis and septic shock: a systematic review. Curr Med Res Opin. 2015;31:1817\u201325.","journal-title":"Curr Med Res Opin"},{"key":"3024_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.lfs.2014.05.007","volume":"118","author":"Y Ogura","year":"2014","unstructured":"Ogura Y, Jesmin S, Yamaguchi N, Oki M, Shimojo N, Islam MM, et al. Potential amelioration of upregulated renal HIF-1alpha\u2013endothelin-1 system by landiolol hydrochloride in a rat model of endotoxemia. Life Sci. 2014;118:347\u201356.","journal-title":"Life Sci"},{"key":"3024_CR43","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00134-011-2326-x","volume":"37","author":"K Mori","year":"2011","unstructured":"Mori K, Morisaki H, Yajima S, Suzuki T, Ishikawa A, Nakamura N, et al. Beta-1 blocker improves survival of septic rats through preservation of gut barrier function. Intensive Care Med. 2011;37:1849\u201356.","journal-title":"Intensive Care Med"},{"key":"3024_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.lfs.2014.04.005","volume":"118","author":"Y Seki","year":"2014","unstructured":"Seki Y, Jesmin S, Shimojo N, Islam MM a, Rahman MA r, Khatun T, et al. Significant reversal of cardiac upregulated endothelin-1 system in a rat model of sepsis by landiolol hydrochloride. Life Sci. 2014;118:357\u201363.","journal-title":"Life Sci"},{"issue":"4","key":"3024_CR45","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1186\/cc6976","volume":"12","author":"CA Schmittinger","year":"2008","unstructured":"Schmittinger CA, D\u00fcnser MW, Haller M, Ulmer H, Luckner G, Torgersen C, et al. Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression. Crit Care. 2008;12(4):R99.","journal-title":"Crit Care"},{"key":"3024_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.lfs.2016.10.010","volume":"166","author":"Y Matsuishi","year":"2016","unstructured":"Matsuishi Y, Jesmin S, Kawano S, Hideaki S, Shimojo N, Mowa CN, et al. Landiolol hydrochloride ameliorates acute lung injury in a rat model of early sepsis through the suppression of elevated levels of pulmonary endothelin-1. Life Sci. 2016;166:27\u201333.","journal-title":"Life Sci"},{"key":"3024_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0300-9572(86)90068-7","volume":"14","author":"G Azimi","year":"1986","unstructured":"Azimi G, Vincent JL. Ultimate survival from septic shock. Resuscitation. 1986;14:245\u201353.","journal-title":"Resuscitation"},{"key":"3024_CR48","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/00003246-198710000-00006","volume":"15","author":"MM Parker","year":"1987","unstructured":"Parker MM, Shelhamer JH, Natanson C, Alling DW, Parrillo JE. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis. Crit Care Med. 1987;15:923\u20139.","journal-title":"Crit Care Med"},{"key":"3024_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5492\/wjccm.v4.i3.251","volume":"4","author":"M Okajima","year":"2015","unstructured":"Okajima M, Takamura M, Taniguchi T. Landiolol, an ultra-short-acting \u03b21-blocker, is useful for managing supraventricular tachyarrhythmias in sepsis. World J Crit Care Med. 2015;4:251\u20137.","journal-title":"World J Crit Care Med"},{"key":"3024_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinane.2017.07.009","volume":"42","author":"T Tamura","year":"2017","unstructured":"Tamura T, Yatabe T, Yokoyama M. Prevention of atrial fibrillation after cardiac surgery using low-dose landiolol: A systematic review and meta-analysis. J Clin Anesth. 2017;42:1\u20136.","journal-title":"J Clin Anesth"},{"key":"3024_CR51","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1253\/circj.CJ-12-1618","volume":"77","author":"R Nagai","year":"2013","unstructured":"Nagai R, Kinugawa K, Inoue H, Atarashi H, Seino Y, Yamashita T, et al. Urgent management of rapid heart rate in patients with atrial fibrillation\/flutter and left ventricular dysfunction: comparison of the ultra-short-acting \u03b21-selective blocker landiolol with digoxin (J-Land Study). Circ J. 2013;77:908\u201316.","journal-title":"Circ J"},{"key":"3024_CR52","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40265-018-0883-9","volume":"78","author":"YY Syed","year":"2018","unstructured":"Syed YY. Landiolol: a review in tachyarrhythmias. Drugs. 2018;78:377\u201388.","journal-title":"Drugs"},{"key":"3024_CR53","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00228-016-2176-0","volume":"73","author":"G Krumpl","year":"2017","unstructured":"Krumpl G, Ulc I, Trebs M, Kadlecov\u00e1 P, Hodisch J. Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group. Eur J Clin Pharmacol. 2017;73:417\u201328.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3024_CR54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/FJC.0000000000000554","volume":"71","author":"G Krumpl","year":"2018","unstructured":"Krumpl G, Ulc I, Trebs M, Kadlecov\u00e1 P, Hodisch J, Maurer G, et al. Pharmacokinetics and pharmacodynamics of low-, intermediate-, and high-dose landiolol and esmolol during long-term infusion in healthy whites. J Cardiovasc Pharmacol. 2018;71(3):137\u201346.","journal-title":"J Cardiovasc Pharmacol"},{"key":"3024_CR55","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejps.2016.06.022","volume":"92","author":"G Krumpl","year":"2016","unstructured":"Krumpl G, Ulc I, Trebs M, Kadlecov\u00e1 P, Hodisch J. Pharmacokinetics and pharmacodynamics of two different landiolol formulations in a healthy Caucasian group. Eur J Pharm Sci. 2016;92:64\u201373.","journal-title":"Eur J Pharm Sci"},{"key":"3024_CR56","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00540-008-0640-4","volume":"22","author":"K Ikeshita","year":"2008","unstructured":"Ikeshita K, Nishikawa K, Toriyama S, Yamashita T, Tani Y, Yamada T, et al. Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts. J Anesth. 2008;22:361\u20136.","journal-title":"J Anesth"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-3024-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-3024-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-3024-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T12:24:36Z","timestamp":1589977476000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-3024-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3024"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-3024-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"assertion":[{"value":"5 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approvals of central ethics committees are listed in Table .","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MU, GK, BGI, MZ, KK, and CK are employees of AOP Pharmaceuticals AG, OB is an employee of Amomed Pharma GmbH.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"637"}}